Mr. Andy Sheldon

• 
  www.marketwire.com/mw/release.do?id=863259 - [Cached Version]
  Published on: 6/2/2008    Last Visited: 6/2/2008  

  QUEBEC CITY, QUEBEC--(Marketwire - June 2, 2008) - Medicago Inc. (TSX VENTURE:MDG) (the "Company"), today announced that Mr. Andy Sheldon, President and CEO, will participate in a panel discussion entitled "Addressing the limited global capacity in producing pandemic and seasonal flu vaccines" at the World Vaccine Congress Asia 2008.The conference will be held at the Grand Hyatt Singapore, Singapore, from June 2-5, 2008.
  
  During the session, Mr. Sheldon and other leading vaccine experts will describe what are the technical manufacturing challenges and strategies to increase vaccine production capacity, as well as discuss the continuous progress to improve vaccine production technology and production of vaccines for broader protection.
  ...
  Andy Sheldon President and CEO418-658-9393

• 
  www.newswire.ca/en/releases/archive/July2008/03/c9516.h - [Cached Version]
  Published on: 7/4/2008    Last Visited: 7/4/2008  

  national de recherches du Canada", a souligné Andy Sheldon, président et chef de la direction de Medicago.
  ...
  Renseignements: Medicago Inc., Andy Sheldon, Président et chef de la direction, (418) 658-9393; Relations avec les investisseurs: The Equicom Group

• 
  www.newswire.ca/en/releases/archive/March2008/11/c2845. - [Cached Version]
  Published on: 3/11/2008    Last Visited: 3/11/2008  

  "Company"), today announced that Mr. Andy Sheldon, President and CEO, will be presenting at the Partnering for Global Health Forum 2008 in Washington, DC, today at 3:30 p.m. EST.Mr. Sheldon will give an overview of the Company's development of vaccines and manufacturing technologies, and recent preclinical
  ...
  For further information: Medicago Inc., Andy Sheldon, President and CEO, (418) 658-9393; The Equicom Group Inc., Arianna Vanin, Investor Relations,

• 
  www.biofinance.ca/Schedule - [Cached Version]
  Published on: 1/27/2005    Last Visited: 9/6/2006  

  Andy Sheldon

• 
  www.cnxmarketlink.com/en/releases/archive/July2008/15/c - [Cached Version]
  Published on: 7/16/2008    Last Visited: 7/16/2008  

  before the first wave of the pandemic strikes," said Andy Sheldon, President and CEO of Medicago.
  ...
  efforts to commercialize this technology globally," added Mr. Sheldon.
  ...
  /For further information: Medicago, Inc., Andy Sheldon, President and CEO, (418) 658-9393; Investor relations: The Equicom Group Inc., Arianna Vanin, (514) 844-4680, avanin@equicomgroup.com/

• 
  www.cnxmarketlink.com/en/releases/archive/August2008/05 - [Cached Version]
  Published on: 7/8/2008    Last Visited: 8/8/2008  

  that its President and CEO, Mr. Andy Sheldon, is a member of the delegation
  ...
  Mr. Sheldon will meet with health officials of the province of Shandong to present Medicago's proprietary plant-based vaccine development and production technologies and how the Company is able to address pandemic planning in the most efficient and effective manner. "Ongoing outbreaks of H5N1 Avian Influenza in Asia pose a significant risk for a pandemic emphasizing the importance of preparedness in this region of the world," said Andy Sheldon, President and CEO of Medicago.
  ...
  /For further information: Medicago, Inc., Andy Sheldon, President and CEO, (418) 658-9393; Investor relations: The Equicom Group Inc., Arianna Vanin, (514) 844-4680, avanin@equicomgroup.com/

• 
  www.newswire.ca/en/releases/archive/July2008/03/c9513.h - [Cached Version]
  Published on: 7/4/2008    Last Visited: 7/4/2008  

  2001 with Canada's National Research Council," said Andy Sheldon, President and CEO of Medicago."The development of a seasonal influenza vaccine
  ...
  For further information: Contact: Medicago, Inc., Andy Sheldon, President and CEO, (418) 658-9393; Investor relations: The Equicom Group Inc.,

• 
  www.mawba.com/gallery_pandemicplan.html - [Cached Version]
  Published on: 7/1/2008    Last Visited: 8/3/2008  

  This rapid time frame is critical as it could allow the vaccination of a population before the first wave of the pandemic strikes," said Andy Sheldon, President and CEO of Medicago."As we are able to rapidly produce new vaccines in large quantities, we have been in discussions with several countries in Europe, Asia and Africa for the establishment of partnerships to create domestic vaccine production infrastructures based on Medicago's technologies."
  
  "In particular, we are excited to be exploring this opportunity in greater detail in France, where the objective is to establish a facility that offers surge capacity to produce pandemic vaccine doses and eventually other biodefense related products, as well as offering bioproduction services to local companies.
  
  We expect to complete all necessary studies by the end of 2008 and greatly appreciate the support of the Quebec government for our efforts to commercialize this technology globally," added Mr. Sheldon.

• 
  www.newswire.ca/en/releases/archive/June2008/25/c7413.h - [Cached Version]
  Published on: 6/26/2008    Last Visited: 6/26/2008  

  virus," said Andy Sheldon, President and CEO of Medicago."These unique
  ...
  For further information: Medicago, Inc., Andy Sheldon, President and CEO, (418) 658-9393; Investor relations, The Equicom Group Inc., Arianna Vanin, (514) 844-4680, avanin@equicomgroup.com

• 
  www.cnxmarketlink.ca/en/releases/archive/November2007/2 - [Cached Version]
  Published on: 11/21/2007    Last Visited: 11/21/2007  

  vaccine development," said Andy Sheldon, President and CEO.
  ...
  /For further information: Contact Information: Medicago Inc., Andy Sheldon, President and CEO, (418) 658-9393; The Equicom Group Inc., Eric Bouchard, Investor Relations, (514) 844-7997, ebouchard@equicomgroup.com/

Page:  1 2 3 4 5